TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27727445

Group type: EXPERIMENTAL
Intervention: Advair Diskus 100/50
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional two-way crossover design
Number of subjects: 0
Study: 25408262

Group type: EXPERIMENTAL
Intervention: Test formulation of erlotinib 150 mg
Number of subjects: 46

Group type: COMPARATOR
Intervention: Reference formulation of erlotinib 150 mg
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: CYP1A2*1M genotype
Number of subjects: 46
Study: 23886915

Group type: EXPERIMENTAL
Intervention: High-intensity statin therapy (rosuvastatin 40 mg or atorvastatin 80 mg)
Number of subjects: 1039
Study: 21466699

Group type: EXPERIMENTAL
Intervention: Personalised e‐health support intervention
Number of subjects: 39
Study: 20351899

Group type: EXPERIMENTAL
Intervention: Letter reminder
Number of subjects: 1397

Group type: EXPERIMENTAL
Intervention: Email reminder
Number of subjects: 1397

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1397
Study: 16691030

Group type: EXPERIMENTAL
Intervention: 1% pimecrolimus cream (Elidel) applied twice daily for 2 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vehicle control applied twice daily for 2 weeks
Number of subjects: 20
Study: 15301621

Group type: EXPERIMENTAL
Intervention: Increasing target duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing mask duration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lateral inhibition model
Number of subjects: 0
Study: 11778974

Group type: EXPERIMENTAL
Intervention: CHOP
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: MACOP-B
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Pretreatment global QoL
Number of subjects: 95

Group type: COMPARATOR
Intervention: Reference population
Number of subjects: 95
Study: 9502601

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pyrimethamine/sulfadoxine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chloroquine (in laboratory infections)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pyrimethamine/sulfadoxine (in laboratory infections)
Number of subjects: 0
Study: 7934970

Group type: EXPERIMENTAL
Intervention: Acipimox slow release (ACX‐SR, 500 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3154706

Group type: COMPARATOR
Intervention: Metoprolol (100 mg twice daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Verapamil (80 mg three times a day) plus Metoprolol (100 mg twice daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nitrendipine (20 mg twice daily) plus Metoprolol (100 mg twice daily)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Verapamil and Nitrendipine
Number of subjects: 8
Study: 29084372

Group type: EXPERIMENTAL
Intervention: 1 μg of HGF per vocal fold
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 3 μg of HGF per vocal fold
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10 μg of HGF per vocal fold
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 18
Study: 27411000

Group type: EXPERIMENTAL
Intervention: 1st-person point of view narrative
Number of subjects: 0

Group type: COMPARATOR
Intervention: 3rd-person point of view narrative
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Similar protagonist (young, same sex)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dissimilar protagonist (older, opposite sex)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-referencing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Susceptibility and severity perceptions
Number of subjects: 0
Study: 23930950

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus (10⁹ colony-forming units twice daily; n=20)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (n=19)
Number of subjects: 39
Study: 24161011

Group type: EXPERIMENTAL
Intervention: Electromagnetic computer‐assisted navigation (group I: 75 patients, 80 knees)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Without electromagnetic computer‐assisted navigation (group II: 76 patients, 80 knees)
Number of subjects: 151
Study: 20500318

Group type: EXPERIMENTAL
Intervention: Single application of lidocaine (one application five minutes prior to catheterisation)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Two applications of lidocaine (two applications spaced five minutes apart prior to catheterisation)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Single application of lidocaine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Two applications of lidocaine
Number of subjects: 200
Study: 18793340

Group type: EXPERIMENTAL
Intervention: True eradication therapy
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo eradication therapy
Number of subjects: 183
Study: 16885070

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 790

Group type: COMPARATOR
Intervention: Control (no abciximab)
Number of subjects: 790
Study: 14648521

Group type: EXPERIMENTAL
Intervention: Oral sucrose and non‐nutritive sucking (NNS)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Sucrose alone
Number of subjects: 190

Group type: COMPARATOR
Intervention: Sterile water and NNS (control)
Number of subjects: 190
Study: 10820932

Group type: EXPERIMENTAL
Intervention: Accelerated streptokinase infusion over 15 minutes (group 1, n = 24)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional streptokinase infusion over one hour (group 2, n = 23)
Number of subjects: 47
Study: 8648213

Group type: EXPERIMENTAL
Intervention: Single oral doses of Ty800 (10^7, 10^8, 10^9, or 10^10 cfu)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control vaccinees received 4 oral doses of S. typhi Ty21a
Number of subjects: 11
Study: 7645789

Group type: EXPERIMENTAL
Intervention: Midazolam plus fentanyl
Number of subjects: 207

Group type: COMPARATOR
Intervention: Midazolam alone
Number of subjects: 207
Study: 3536031

Group type: EXPERIMENTAL
Intervention: Povidone iodine impregnated dressing (Inadine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard petroleum jelly gauze dressing
Number of subjects: 0
Study: 29287237

Group type: EXPERIMENTAL
Intervention: Inhalation of essential oil
Number of subjects: 34

Group type: COMPARATOR
Intervention: Inhalation of perfume
Number of subjects: 34
Study: 27217266

Group type: EXPERIMENTAL
Intervention: Peer mentoring intervention (2 in-person sessions and 5 phone calls over 10 weeks)
Number of subjects: 460

Group type: COMPARATOR
Intervention: Control intervention (didactic sessions on avoiding HIV transmission)
Number of subjects: 460
Study: 24893862

Group type: EXPERIMENTAL
Intervention: Behavioral weight control intervention
Number of subjects: 118
Study: 23844489

Group type: EXPERIMENTAL
Intervention: Phonophoresis combined with stretching exercise
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ultrasound combined with stretching exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stretching exercise
Number of subjects: 30
Study: 20724597

Group type: EXPERIMENTAL
Intervention: Targeting Cdc7 with RNAi
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cdc7 kinase activity recovery in untransformed breast epithelial cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Increased Cdc7 expression
Number of subjects: 0
Study: 18717717

Group type: EXPERIMENTAL
Intervention: Anodal tDCS of the primary motor cortex (M1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Anodal tDCS of the dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Occipital cortex (V1) stimulation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study: 16470242

Group type: EXPERIMENTAL
Intervention: Telephone support and educational materials from oncology nurses
Number of subjects: 77

Group type: COMPARATOR
Intervention: Educational materials only (Control)
Number of subjects: 77
Study: 12499327

Group type: EXPERIMENTAL
Intervention: Low-GI dietary advice
Number of subjects: 104

Group type: COMPARATOR
Intervention: Traditional carbohydrate-exchange dietary advice (CHOx)
Number of subjects: 104
Study: 11030499

Group type: EXPERIMENTAL
Intervention: Stretching intervention (30 minutes of daily stretching into dorsiflexion with a torque of 7.5 N x m for 4 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no stretches on contralateral ankles)
Number of subjects: 14
Study: 8800496

Group type: EXPERIMENTAL
Intervention: High plasma content of vitamin E
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Lipid standardised vitamin E
Number of subjects: 406
Study: 1531200

Group type: EXPERIMENTAL
Intervention: GnRH‐a
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no GnRH‐a)
Number of subjects: 30
Study: 6400113

Group type: EXPERIMENTAL
Intervention: Sodium restriction for eight weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 18
Study: 30879820

Group type: EXPERIMENTAL
Intervention: Reconstituted alfalfa hay (RAH)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dry alfalfa hay (AH)
Number of subjects: 20
Study: 29499722

Group type: EXPERIMENTAL
Intervention: Antibiotics and regular clinical assessment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Appendicectomy
Number of subjects: 0
Study: 26806141

Group type: EXPERIMENTAL
Intervention: Spiritual assessment with traditional treatment
Number of subjects: 84

Group type: COMPARATOR
Intervention: Usual treatment only (Control)
Number of subjects: 84
Study: 25332329

Group type: EXPERIMENTAL
Intervention: Meat group (pureed meats)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Cereal group (infant cereal)
Number of subjects: 42
Study: 22872029

Group type: EXPERIMENTAL
Intervention: High Glycaemic Load (HGL): 7g protein, 9g fat, 50g carbohydrate, GL 33
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Medium Glycaemic Load (MGL): 14g protein, 9g fat, 45g carbohydrate, GL 24
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Low Glycaemic Load (LGL): 18g protein, 10g fat, 38g carbohydrate, GL 18
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 39
Study: 20461799

Group type: EXPERIMENTAL
Intervention: ParkinsonNet intervention (implemented in 8 experimental regions)
Number of subjects: 699

Group type: COMPARATOR
Intervention: Usual care (control group, 8 regions with unchanged organization of care)
Number of subjects: 699
Study: 17904226

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 516

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 516
Study: 15764762

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Celiprolol (200 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 12352386

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 1112
Study: 10100058

Group type: EXPERIMENTAL
Intervention: Arm position on the arm-rest of the chair
Number of subjects: 69

Group type: COMPARATOR
Intervention: Arm position at the level of the mid-sternum (right atrial level)
Number of subjects: 69
Study: 7768272

Group type: EXPERIMENTAL
Intervention: 7.5 mg glyburide
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 2221162

Group type: EXPERIMENTAL
Intervention: Desipramine and individual psychotherapy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo plus psychotherapy
Number of subjects: 28
Study: 1127891

Group type: EXPERIMENTAL
Intervention: Aggressive model
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Altruistic model
Number of subjects: 120

Group type: COMPARATOR
Intervention: Different treatment conditions
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Aggressive or altruistic behavior in the first situation
Number of subjects: 120
Study: 30269100

Group type: COMPARATOR
Intervention: 0 min adaptation after ambient light exposure
Number of subjects: 50

Group type: COMPARATOR
Intervention: 5 min adaptation after ambient light exposure
Number of subjects: 50

Group type: COMPARATOR
Intervention: 10 min adaptation after ambient light exposure
Number of subjects: 50

Group type: COMPARATOR
Intervention: 15 min adaptation after ambient light exposure
Number of subjects: 50

Group type: COMPARATOR
Intervention: 20 min adaptation after ambient light exposure
Number of subjects: 50

Group type: COMPARATOR
Intervention: 30 min adaptation after ambient light exposure
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0 min adaptation after bright light exposure
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10 min adaptation after bright light exposure
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 20 min adaptation after bright light exposure
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0 min adaptation after ambient light exposure in choroideremia
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 20 min adaptation after ambient light exposure in choroideremia
Number of subjects: 50
Study: 29381917

Group type: EXPERIMENTAL
Intervention: Cervical kyphosis patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 60
Study: 26094695

Group type: EXPERIMENTAL
Intervention: Thymalfasin (1.6 mg twice a week for 12 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 22420329

Group type: EXPERIMENTAL
Intervention: DC + M2 (denture cleanser for 3 min with 2 min microwave irradiation)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: DC + M3 (denture cleanser for 3 min with 3 min microwave irradiation)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: DW + M3 (distilled water for 3 min with 3 min microwave irradiation)
Number of subjects: 7

Group type: COMPARATOR
Intervention: DW (distilled water for 3 min with 0 min microwave irradiation)
Number of subjects: 7

Group type: COMPARATOR
Intervention: DW + M1 (distilled water for 3 min with 1 min microwave irradiation)
Number of subjects: 7

Group type: COMPARATOR
Intervention: DC (denture cleanser for 3 min with 0 min microwave irradiation)
Number of subjects: 7
Study: 21613558

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D concentrations (≥52 nmol/L)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Serum 25-hydroxyvitamin D concentrations
Number of subjects: 292
Study: 19220313

Group type: EXPERIMENTAL
Intervention: Memantine 20-40 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17124558

Group type: EXPERIMENTAL
Intervention: Highly purified omega-3 fatty acid ethylesters (omega-3-acid ethyl esters 90=Zodin)
Number of subjects: 0
Study: 12510010

Group type: EXPERIMENTAL
Intervention: Pentagastrin (CCK-B receptor agonist)
Number of subjects: 0
Study: 10881555

Group type: EXPERIMENTAL
Intervention: Primary cognitive tasks performed concurrently with secondary executive tasks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Secondary executive tasks
Number of subjects: 0
Study: 9394638

Group type: EXPERIMENTAL
Intervention: Standing unladen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Handling a load
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Holding a load with one hand on the shoulder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased separation of the feet
Number of subjects: 0
Study: 8245901

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 3927356

Group type: EXPERIMENTAL
Intervention: Cianopramine (n = 20, mean daily dose 3.3 +/- 0.6 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amitriptyline (n = 20, mean daily dose 86.4 +/- 21 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 60
Study: 30383646

Group type: EXPERIMENTAL
Intervention: Electrocardiographic left ventricular hypertrophy
Number of subjects: 17312

Group type: EXPERIMENTAL
Intervention: Electrocardiographic left ventricular hypertrophy in males
Number of subjects: 17312

Group type: EXPERIMENTAL
Intervention: Electrocardiographic left ventricular hypertrophy in females
Number of subjects: 17312

Group type: EXPERIMENTAL
Intervention: Electrocardiographic left ventricular hypertrophy in patients with comorbid diabetes
Number of subjects: 17312
Study: 26843483

Group type: EXPERIMENTAL
Intervention: Expert raters (n = 5)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Attendees of the EULAR capillaroscopy course (n = 34)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Novices after a 1-h course (n = 11)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal vs combined groups of abnormal and not evaluable capillaries (Expert raters)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal vs combined groups of abnormal and not evaluable capillaries (Attendees)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal vs combined groups of abnormal and not evaluable capillaries (Novices)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Classifiable capillaries (Expert raters)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Classifiable capillaries (Attendees)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Classifiable capillaries (Novices)
Number of subjects: 50
Study: 24846789

Group type: EXPERIMENTAL
Intervention: Smiling condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frowning condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 0
Study: 22434327

Group type: EXPERIMENTAL
Intervention: Good Behavior Game (GBG) intervention, with training and weekly on-site support from coaches.
Number of subjects: 8
Study: 20362342

Group type: EXPERIMENTAL
Intervention: Simultaneous immunizations (experimental group)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Sequential immunizations (control group)
Number of subjects: 101
Study: 18543367

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 374
Study: 15896512

Group type: EXPERIMENTAL
Intervention: Oligofructose (OF) 6 g daily for 15 days
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sucrose (Control group)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Healthy subjects (control)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Burn patients
Number of subjects: 41
Study: 12224473

Group type: EXPERIMENTAL
Intervention: TENS to the common peroneal nerve
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: TENS to the cutaneous branches of the peroneal nerve
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 43
Study: 10065691

Group type: EXPERIMENTAL
Intervention: Domperidone (a selective dopamine D2‐receptor antagonist)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (normal subjects, N=9)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Patients with OSAS
Number of subjects: 16
Study: 8522792

Group type: EXPERIMENTAL
Intervention: Clothing ensemble HALF (half-sleeved shirts, knee-length trousers, sandals, hat)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Clothing ensemble LONG (long-sleeved shirts, long trousers, gloves, socks, walking shoes, hat)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Clothing ensemble HALF
Number of subjects: 7

Group type: COMPARATOR
Intervention: Clothing ensemble LONG
Number of subjects: 7
Study: 1959848

Group type: EXPERIMENTAL
Intervention: Sclerotherapy (paravenous polidocanol [10 mg/ml] every 1 to 2 weeks until eradication)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Propranolol (slow-release preparation in one daily dose adjusted to provide about 25% heart rate reduction)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Both sclerotherapy and propranolol
Number of subjects: 286

Group type: COMPARATOR
Intervention: Control group (neither sclerotherapy nor propranolol)
Number of subjects: 286
Study: 6112024

Group type: EXPERIMENTAL
Intervention: Phenelzine-exposure
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Phenelzine-no exposure
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Placebo-exposure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo-no exposure
Number of subjects: 40
Study: 31483000

Group type: EXPERIMENTAL
Intervention: Intensive caregiver education program (ICEP)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control group (usual education and guidance)
Number of subjects: 196
Study: 28486851

Group type: EXPERIMENTAL
Intervention: Family-based behavioral weight-loss program (the TODAY Lifestyle Program)
Number of subjects: 234
Study: 25312529

Group type: EXPERIMENTAL
Intervention: LigaSure™ tissue fusion technology with the ForceTriad™ energy platform (LS)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard treatment (ST) - conventional electrosurgical pencil
Number of subjects: 146
Study: 23386756

Group type: EXPERIMENTAL
Intervention: Enhanced information group (received pamphlet and physiotherapy handout)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard treatment group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Enhanced information group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 21750125

Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg/day
Number of subjects: 334

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study: 19042026

Group type: EXPERIMENTAL
Intervention: Risperidone 0.5-4 mg/day
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 15789141

Group type: EXPERIMENTAL
Intervention: Bovine colostrum (COL; 20 g daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA; 20 g maltodextrin daily)
Number of subjects: 12
Study: 12460229

Group type: EXPERIMENTAL
Intervention: Oral clodronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous pamidronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bisphosphonates
Number of subjects: 0
Study: 10362390

Group type: EXPERIMENTAL
Intervention: Cryotherapy (cold water immersion at 15 degrees C for 15 min immediately after exercise and every 12 h for 15 min for a total of seven sessions)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 15